APA (7th ed.) Citation

Ailawadhi, S., Parrondo, R. D., Dutta, N., Han, B., Ciccio, G., Cherukuri, Y., . . . Chanan-Khan, A. A. (2023). AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma. Cancers, 15(2), 477. https://doi.org/10.3390/cancers15020477

Chicago Style (17th ed.) Citation

Ailawadhi, Sikander, et al. "AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma." Cancers 15, no. 2 (2023): 477. https://doi.org/10.3390/cancers15020477.

MLA (9th ed.) Citation

Ailawadhi, Sikander, et al. "AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma." Cancers, vol. 15, no. 2, 2023, p. 477, https://doi.org/10.3390/cancers15020477.